Stealth BioTherapeutics Corp
Utility Patent Applications
Last updated:
List of all Stealth BioTherapeutics Corp patents 43 in total
| Status | Patent |
|---|---|
Application | Utility: MITOCHONDRIA-TARGETING PEPTIDES Filling date: 9 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BARTH SYNDROME Filling date: 9 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY Filling date: 9 Sep 2025 Issue date: 30 Dec 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR THE TREATMENT OF TRAUMATIC OPTIC NEUROPATHY Filling date: 9 Sep 2025 Issue date: 28 Oct 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA Filling date: 9 Sep 2025 Issue date: 14 Oct 2021 |
Application | Utility: CRYSTALLINE SALT FORMS OF BOC-D-ARG-DMT-LYS-(BOC)-PHE-NH2 Filling date: 9 Sep 2025 Issue date: 23 Sep 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA Filling date: 9 Sep 2025 Issue date: 22 Jul 2021 |
Application | Utility: COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA Filling date: 9 Sep 2025 Issue date: 8 Jul 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS Filling date: 9 Sep 2025 Issue date: 27 May 2021 |
Application | Utility: AROMATIC-CATIONIC PEPTIDES AND USES OF SAME Filling date: 9 Sep 2025 Issue date: 6 May 2021 |
Application | Utility: CRYSTALLINE BIS- AND TRIS-HYDROCHLORIDE SALT OF ELAMIPRETIDE Filling date: 9 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: CRYSTALLINE SALT FORMS Filling date: 9 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE Filling date: 9 Sep 2025 Issue date: 18 Feb 2021 |
Application | Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY Filling date: 9 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: AROMATIC-CATIONIC PEPTIDES AND USES OF SAME Filling date: 9 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: METHODS OF IDENTIFYING AND MONITORING MITOCHONDRIAL DYSFUNCTION USING MONOCYTE SCREENING Filling date: 9 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY Filling date: 9 Sep 2025 Issue date: 28 Jan 2021 |
Application | Utility: METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE Filling date: 9 Sep 2025 Issue date: 31 Dec 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY Filling date: 9 Sep 2025 Issue date: 24 Dec 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE Filling date: 9 Sep 2025 Issue date: 3 Dec 2020 |
Application | Utility: CRYSTALLINE SALT FORMS OF BOC-D-ARG-DMT-LYS-(BOC)-PHE-NH2 Filling date: 9 Sep 2025 Issue date: 26 Nov 2020 |
Application | Utility: METHODS FOR REDUCING RISKS ASSOCIATED WITH HEART FAILURE AND FACTORS ASSOCIATED THEREWITH Filling date: 9 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: DEUTERATED TETRAPEPTIDES THAT TARGET MITOCHONDRIA Filling date: 9 Sep 2025 Issue date: 19 Nov 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION OR TREATMENT OF BARTH SYNDROME Filling date: 9 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: PROCESSES FOR PREPARING PHARMACEUTICALLY RELEVANT PEPTIDES Filling date: 9 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: CRYSTALLINE DIPEPTIDES USEFUL IN THE SYNTHESIS OF ELAMIPRETIDE Filling date: 9 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: AROMATIC-CATIONIC PEPTIDES AND METHODS FOR USING SAME Filling date: 9 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: NEUTRAL-CATIONIC PEPTOIDS AND USES THEREOF Filling date: 9 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR REGULATING SRCA2A EXPRESSION LEVELS IN MYOCARDIAL INFARCTION Filling date: 9 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS Filling date: 9 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: PHARMACEUTICALLY RELEVANT AROMATIC-CATIONIC PEPTIDES Filling date: 9 Sep 2025 Issue date: 23 Jan 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR DETECTING AND DIAGNOSING DISEASES AND CONDITIONS Filling date: 9 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: METHODS FOR TREATMENT OF ATHEROSCLEROSIS Filling date: 9 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF FRIEDREICH'S ATAXIA Filling date: 9 Sep 2025 Issue date: 26 Dec 2019 |
Application | Utility: PEPTIDE THERAPEUTICS AND METHODS FOR USING SAME Filling date: 9 Sep 2025 Issue date: 12 Dec 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY Filling date: 9 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE Filling date: 9 Sep 2025 Issue date: 5 Dec 2019 |
Application | Utility: METHODS FOR THE PREVENTION OR TREATMENT OF LEFT VENTRICLE REMODELING Filling date: 9 Sep 2025 Issue date: 28 Nov 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT NEUROPATHY Filling date: 9 Sep 2025 Issue date: 14 Nov 2019 |
Application | Utility: METHODS FOR THE PREVENTION OR TREATMENT OF VESSEL OCCLUSION INJURY Filling date: 9 Sep 2025 Issue date: 7 Nov 2019 |
Application | Utility: METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING DOMINANT OPTIC ATROPHY Filling date: 9 Sep 2025 Issue date: 31 Oct 2019 |
Application | Utility: COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF MITOCHONDRIAL MYOPATHIES Filling date: 9 Sep 2025 Issue date: 12 Sep 2019 |
Application | Utility: CRYSTALLINE BIS- AND TRIS-HYDROCHLORIDE SALT OF ELAMIPRETIDE Filling date: 9 Sep 2025 Issue date: 1 Aug 2019 |
Showing 1 to 43 of 43 patents.